单绒毛膜与双绒毛膜双胎妊娠计划阴道分娩后的围产期结局比较
基于法国JUMODA前瞻性队列,纳入3873例计划阴道分娩、孕≥32周且第一胎头位的双胎妊娠,比较无并发症单绒毛膜与双绒毛膜双胎的围产期复合结局。单绒毛膜组与双绒毛膜组的复合产时死亡及新生儿发病率死亡率无显著差异(调整后相对风险1.07,95%CI 0.66-1.75)。
要点
- 无并发症单绒毛膜双胎计划阴道分娩时,复合产时死亡及新生儿发病率死亡率与双绒毛膜双胎无显著差异。
- 该结论基于孕≥32周且第一胎头位、符合Twin Birth Study入选标准的人群。
- 单绒毛膜双胎合并双胎输血综合征或双胎贫血-红细胞增多序列征被定义为复杂病例并排除。
核心结论
- 计划阴道分娩且孕≥32周第一胎头位时,无并发症单绒毛膜双胎妊娠的复合产时死亡及新生儿发病率死亡率与双绒毛膜双胎妊娠相比无显著差异。
研究设计与样本
- JUMODA是一项法国全国前瞻性人群队列研究,2014年2月至2015年3月在176个产科单位分娩的双胎妊娠。
- 本分析为计划二次分析,评估计划阴道分娩、孕≥32周且第一胎头位的双胎妊娠,按绒毛膜性分组。
- 采用与Twin Birth Study相同的排除标准,排除合并双胎输血综合征或双胎贫血-红细胞增多序列征的复杂单绒毛膜双胎。
- 共纳入3873例双胎妊娠,其中无并发症单绒毛膜双胎729例(18.8%),双绒毛膜双胎3144例(81.2%)。
- 主要结局为产时死亡与新生儿发病率及死亡率的复合结局,采用多因素logistic回归控制潜在混杂因素。
诊断标准与关键数值
- 主要结局为产时死亡与新生儿发病率及死亡率的复合结局。
- 无并发症单绒毛膜双胎组复合结局发生27/1458(1.9%),双绒毛膜双胎组107/6288(1.7%)。
- 调整辅助生殖技术受孕后,调整后相对风险为1.07(95%CI 0.66-1.75),两组无显著差异。
- 按胎次(第一胎或第二胎)及分娩孕周(<37周或≥37周)亚组分析,主要结局均无显著差异。
临床应用与阅片要点
- 原文结论可直接复述:计划阴道分娩且孕≥32周第一胎头位时,无并发症单绒毛膜双胎妊娠不伴更高的复合产时死亡及新生儿发病率死亡率。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess, according to chorionicity, the perinatal outcome of twin pregnancy in which vaginal delivery is planned.
METHODS: JUMODA (JUmeaux MODe d'Accouchement) was a national prospective population-based cohort study of twin pregnancies, delivered in 176 maternity units in France, from February 2014 to March 2015. In this planned secondary analysis, we assessed, according to chorionicity, the perinatal outcome of twin pregnancies, in which vaginal delivery was planned, that delivered at or after 32 weeks of gestation with the first twin in cephalic presentation. In order to select a population with well-recognized indications for planned vaginal delivery, we applied the same exclusion criteria as those in the Twin Birth Study, an international randomized trial. Monochorionic twin pregnancies with twin-to-twin transfusion syndrome or twin anemia-polycythemia sequence were defined as complicated and were excluded. The primary outcome was a composite of intrapartum mortality and neonatal morbidity and mortality. Multivariable logistic regression models were used to control for potential confounders. Subgroup analyses were conducted according to birth order (first or second twin) and gestational age at delivery (< 37 or ≥ 37 weeks of gestation).
RESULTS: Among 3873 twin pregnancies, in which vaginal delivery was planned, that delivered at ≥ 32 weeks' gestation with the first twin in cephalic presentation, meeting the inclusion criteria of the Twin Birth Study, 729 (18.8%) were uncomplicated monochorionic twin pregnancies and 3144 (81.2%) were dichorionic twin pregnancies. The rate of composite intrapartum mortality and neonatal morbidity and mortality did not differ between uncomplicated monochorionic (27/1458 (1.9%)) and dichorionic (107/6288 (1.7%)) twin pregnancies when adjusting for conception by assisted reproductive technologies (adjusted relative risk, 1.07 (95% CI, 0.66-1.75)). No significant difference in the primary outcome was found between the groups on subgroup analyses according to birth order and gestational age at delivery.
CONCLUSION: When vaginal delivery is planned, and delivery occurs at ≥ 32 weeks of gestation with the first twin in cephalic presentation, uncomplicated monochorionic twin pregnancy is not associated with a higher rate of composite intrapartum mortality and neonatal morbidity and mortality compared with dichorionic twin pregnancy. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Schmitz T, Korb D, Azria E, et al. Perinatal outcome after planned vaginal delivery in monochorionic compared with dichorionic twin pregnancy. Ultrasound Obstet Gynecol. 2021. PMID: 33078466. doi:10.1002/uog.23518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。